Select a section from the left sidebar
8,8′-dihydroxy-1,1′,3,3′-tetramethoxy-6,6′-dimethyl-10,10′-bianthrone
- Family: Fungi - Trichocomaceae
- Kingdom: Fungi
- Class: Bianthrone
Canonical Smiles | COc1cc(OC)c2c(c1)C(C1c3cc(C)cc(c3C(=O)c3c1cc(OC)cc3OC)O)c1c(C2=O)c(O)cc(c1)C |
---|---|
InChI | InChI=1S/C34H30O8/c1-15-7-19-27(21-11-17(39-3)13-25(41-5)31(21)33(37)29(19)23(35)9-15)28-20-8-16(2)10-24(36)30(20)34(38)32-22(28)12-18(40-4)14-26(32)42-6/h7-14,27-28,35-36H,1-6H3 |
InChIKey | LIZAXDZGERGFKW-UHFFFAOYSA-N |
Formula | C34H30O8 |
HBA | 8 |
HBD | 2 |
MW | 566.61 |
Rotatable Bonds | 5 |
TPSA | 111.52 |
LogP | 5.8 |
Number Rings | 6 |
Number Aromatic Rings | 4 |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Fraction CSP3 | 0.24 |
Exact Mass | 566.19 |
Number of Lipinski Rule Violations | 2 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Aspergillus wentii | Trichocomaceae | Fungi | 5066 |
Showing of synonyms
8,8′-dihydroxy-1,1′,3,3′-tetramethoxy-6,6′-dimethyl-10,10′-bianthrone
77282-67-8
NSC357286
1-hydroxy-10-(5-hydroxy-2,4-dimethoxy-7-methyl-10-oxo-9H-anthracen-9-yl)-6,8-dimethoxy-3-methyl-10H-anthracen-9-one
CHEMBL4566423
DTXSID80320293
NSC-357286
BIANTHRONE DERIV (ASPERGILLUS WENTII)
No compound-protein relationship available.
SMILES: c1cccc(C2=O)c1C(c(c23)cccc3)C(c(c45)cccc5)c6c(C4=O)cccc6
Level: 1
Mol. Weight: 566.61 g/mol
SMILES: c1cccc(c12)Cc3c(C2=O)cccc3
Level: 0
Mol. Weight: 566.61 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -5.15
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.660
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- 6.27
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.470
- Plasma Protein Binding
- 70.72
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Inhibitor
- OATP1B3
- Inhibitor
Excretion
- Clearance
- 6.660
- Organic Cation Transporter 2
- Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- 2.220
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 0.280
- Liver Injury II
- Toxic
- hERG Blockers
- Safe
- Daphnia Maga
- 6.780
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Toxic
- T. Pyriformis
- -13565.380
- Rat (Acute)
- 2.800
- Rat (Chronic Oral)
- 3.000
- Fathead Minnow
- 37.910
- Respiratory Disease
- Safe
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Toxic
General Properties
- Boiling Point
- 465.790
- Hydration Free Energy
- -2.910
- Log(D) at pH=7.4
- 4.800
- Log(P)
- 7.41
- Log S
- -7.24
- Log(Vapor Pressure)
- -15.03
- Melting Point
- 246.32
- pKa Acid
- 7.64
- pKa Basic
- 1.81
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Riboflavin synthase | P0AFU8 | RISA_ECOLI | Escherichia coli | 4 | 0.9222 |
Soluble acetylcholine receptor | Q8WSF8 | Q8WSF8_APLCA | Aplysia californica | 3 | 0.8853 |
Acetylcholinesterase | P21836 | ACES_MOUSE | Mus musculus | 3 | 0.8640 |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q04631 | FNTA_RAT | Rattus norvegicus | 3 | 0.8237 |
Glycylpeptide N-tetradecanoyltransferase | Q4Q5S8 | Q4Q5S8_LEIMA | Leishmania major | 3 | 0.7893 |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q4WP27 | Q4WP27_ASPFU | Aspergillus fumigatus | 3 | 0.7868 |
Ribosomal small subunit pseudouridine synthase A | P0AA43 | RSUA_ECOLI | Escherichia coli | 3 | 0.7655 |
Methionine aminopeptidase 2 | P50579 | MAP2_HUMAN | Homo sapiens | 3 | 0.7535 |
HTH-type transcriptional regulator QacR | P0A0N4 | QACR_STAAU | Staphylococcus aureus | 3 | 0.7393 |
Thymidylate synthase | P00469 | TYSY_LACCA | Lacticaseibacillus casei | 4 | 0.7353 |
4-hydroxyphenylacetate 3-monooxygenase | Q8YHT7 | Q8YHT7_BRUME | Brucella melitensis biotype 1 | 2 | 0.7335 |
Lactotransferrin | P24627 | TRFL_BOVIN | Bos taurus | 2 | 0.7259 |
Mycocyclosin synthase | P9WPP7 | CP121_MYCTU | Mycobacterium tuberculosis | 3 | 0.7159 |
Beta-secretase 1 | P56817 | BACE1_HUMAN | Homo sapiens | 3 | 0.7133 |
Nuclear receptor subfamily 4immunitygroup A member 1 | P22736 | NR4A1_HUMAN | Homo sapiens | 3 | 0.7129 |
Neuropilin-1 | O14786 | NRP1_HUMAN | Homo sapiens | 3 | 0.7054 |
Thymidylate synthase | P00469 | TYSY_LACCA | Lacticaseibacillus casei | 3 | 0.7042 |
Streptavidin | P22629 | SAV_STRAV | Streptomyces avidinii | 3 | 0.7025 |
Thymidylate synthase | P0A884 | TYSY_ECOLI | Escherichia coli | 4 | 0.7000 |